The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics

NCT06059287 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Type 2 Diabetes
Sodium-glucose Co-transporter-2 Inhibitor
Myocardial Fibrosis
Magnetic Resonance Imaging

Interventions

DRUG: Henagliflozin
DRUG: Metformin

Sponsor

RenJi Hospital